December Social Media Round-Up—Forbes America’s Dream Employers, ASH and SABCS 2024, and More

Welcome to 2025! We’re excited to look back on our latest social media highlights from December as we plunge headfirst into the new year.

CEO Albert Bourla looked to the future by sharing Pfizer’s goals and continued commitment to making a difference in patients’ lives. Our leadership team conveyed a similar message, from reflecting on Pfizer’s contributions to blood disorder and breast cancer research presented at the American Society of Hematology Annual Meeting and the San Antonio Breast Cancer Symposium, to sharing the PfizerForAll platform’s impact on real people, and much more.

See the latest social posts from our leaders, then check out our corporate channels where we proudly announced Pfizer's inclusion in Forbes’ inaugural list of America’s Dream Employers, shared the latest episodes of “What’s in My Lab” and the “Specialty Voices of Innovation” series, and celebrated International Volunteer Day.

Here’s to a busy 2025!

Executive Leadership

• CEO Albert Bourla reaffirms Pfizer‘s 2024 guidance and shares our outlook for 2025
• Chief U.S. Commercial Officer Aamir Malik reflects on Pfizer’s commitment to patients with transthyretin cardiac amyloidosis (ATTR-CM)
• Chief Digital and Technology Officer Lidia Fonseca shares key takeaways from Pfizer’s AI Festival
• CEO Albert Bourla highlights Pfizer’s presence at 2024 American Society of Hematology Annual Meeting and the San Antonio Breast Cancer Symposium
• Chief Scientific Officer Chris Boshoff shares data from Pfizer’s breast cancer portfolio presented at SABCS 2024
• CEO Albert Bourla completes his term as President of IFPMA and welcomes the incoming president
• Chief U.S. Commercial Officer Aamir Malik shares personal stories from users of the PfizerForAll platform
• Chief People Experience Office Payal Sahni Becher conveys her gratitude for Pfizer colleagues

Pfizer on LinkedIn

• Pfizer ranks first in Drugs and Biotechnology as well as number 25 overall in Forbes’ inaugural list of America’s Dream Employers
• Pfizer takes you behind the science with the team behind our new hemophilia treatment
• Pfizer is named an honoree in the Enduring Impact: 15+ Years in Business category of Fast Company's 2024 Brands That Matter Awards
• Pfizer partners with the National Headache Foundation (NHF) on a migraine series on NHF’s InSights podcast
• Pfizer Multicultural Health Equity Collective shares a recap of the second Health Equity in Action Summit

Pfizer on Instagram

• Pfizer colleagues from across the globe—who have been giving back to their communities through 175 Days of Good—celebrate International Volunteer Day
• PfizerForAll teaches you about migraine science and shows how you can access same-day care
• Pfizer shares the patient story of Bruce, who reflects on his experience dealing with a respiratory virus

Pfizer on X

• Pfizer features more than 75 abstracts at the American Society of Hematology Annual Meeting 2024
• Pfizer Specialty Voices of Innovation series releases its latest episode, sitting down with industry experts to discuss how we can work together to advance a more equitable healthcare system

Pfizer on TikTok

• Pfizer shows you the potential of molecular glues, an exciting development in medicine
• Pfizer’s episode of “What’s in My Lab” introduces you to an ADME scientist who studies what happens to a drug as it moves through the body
• Pfizer teaches you how protein design is transforming disease treatment
• Pfizer’s latest installment of “What’s in My Lab” shares the research of a biophysicist who is using the Nuclear Magnetic Resonance (NMR) lab